Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-07, Stock:JNJ, The news for the past five days is as follows:
2018-05-31: NEWS1: How Novartis’s Business Segments Did in Q1.NEWS2: Assessing GlaxoSmithKline’s Quarterly Revenues.NEWS3: Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis.NEWS4: Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis.NEWS5: Top Diabetes Stocks to Buy Today.NEWS6: How Is JNJ Maintaining Its Momentum in Interventional Solutions?.NEWS7: Johnson & Johnson and the Baby Powder Litigations.NEWS8: How JNJ Is Recreating Its Commercial Model for Medical Devices.NEWS9: Amgen Focused on Advancing Oncology Research Programs in 2018.NEWS10: Johnson & Johnson Responds to Meet Consumer Needs Faster.NEWS11: Sage’s Brexanolone IV: FDA Grants Priority Review.NEWS12: Discussing the Shift in Johnson & Johnson’s Research Strategy.NEWS13: Johnson & Johnson’s Growth Strategy: Expand Emerging Channels.NEWS14: 7 Inflation-Beating Stocks to Consider for This New Reality.NEWS15: 7 Inflation-Beating Stocks to Consider for This New Reality.
2018-06-01: NEWS1: Imerys unit settles talc claims for at least $5 million: Bloomberg.NEWS2: ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF.NEWS3: ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF.NEWS4: How JNJ Is Positioned to Achieve Growth in the Orthopedics Space.NEWS5: Johnson & Johnson’s Over-the-Counter Growth through Innovation.NEWS6: Imerys Unit Said to Settle Talc Claims for at Least $5 Million.NEWS7: Discussing JNJ’s Strategy for Advancing Stroke Treatments.NEWS8: How Johnson & Johnson Is Driving Growth for Beauty Products.NEWS9: Johnson & Johnson Is Reinventing Its Oral Care Franchise.NEWS10: Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks.NEWS11: [$$] Big Pharma on mission to bring immunotherapy to more patients.NEWS12: Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg.NEWS13: Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg.
2018-06-04: NEWS1: What JNJ Has Planned for Its Surgical Business in 2018 and Beyond.NEWS2: Johnson & Johnson a Top 25 Dividend Giant With 2.97% Yield (JNJ).NEWS3: Johnson & Johnson a Top 25 Dividend Giant With 2.97% Yield (JNJ).NEWS4: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 05, 2018.NEWS5: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 05, 2018.NEWS6: JNJ Works on Filling the Portfolio Gaps in Its Spine Business.NEWS7: James Allison, Ph.D., Wins 2018 Dr. Paul Janssen Award for Biomedical Research.NEWS8: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS9: How Johnson & Johnson Plans to Restore Women’s Health Sales.
2018-06-05: NEWS1: Sanofi, Merck and J&J Tout Lower Drug Prices.NEWS2: 3 Biotech Stocks Up in the Past Month on Industry Turnaround.NEWS3: 3 Biotech Stocks Up in the Past Month on Industry Turnaround.NEWS4: Johnson & Johnson Announces Progress Toward Health for Humanity Goals.
2018-06-06: NEWS1: J&J gets $2.7 billion offer for sterilization unit from Fortive.NEWS2: J&J gets $2.7 bln offer for sterilization unit from Fortive.NEWS3: In Missouri, J&J faces biggest trial yet alleging talc caused cancer.NEWS4: J&J to sell sterilization unit to Fortive for $2.7 billion.NEWS5: Fortive to acquire Johnson & Johnson sterilization business for $2.7 billion.NEWS6: Fortive offers $2.7 bln for J&J unit's sterilization business.NEWS7: Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP).NEWS8: Noteworthy Wednesday Option Activity: JNJ, LW, CPB.NEWS9: Noteworthy Wednesday Option Activity: JNJ, LW, CPB.NEWS10: Corrections & Amplifications.NEWS11: Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln.NEWS12: Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln.NEWS13: Boston U. boosts lung cancer research with Johnson & Johnson.NEWS14: The Top 4 UPS Shareholders (UPS).NEWS15: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS16: J&J Faces High-Stakes Trial Over 22 Women's Talc Claims.NEWS17: J&J Facing High-Stakes Talc Trial Over 22 Women's Cancer Claims.NEWS18: Is an Acquisition in Portola Pharmaceuticals' Future?.NEWS19: Is an Acquisition in Portola Pharmaceuticals' Future?.NEWS20: Is an Acquisition in Portola Pharmaceuticals&apos; Future?.

Answer: Rise